Pharmaceutical Technology-04-02-2012

Issue PDF
Pharmaceutical Technology

April 02, 2012

Navigating the Equipment and Machinery Market

Pharmaceutical Technology
Special Reports

April 02, 2012

Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and type of spending made in 2011 and planned for 2012.

Pharmaceutical Technology
Peer-Reviewed Research

April 02, 2012

In Part III of a three-part article, the authors examine various degradation routes of APIs, impurities arising from interactions in formulations, metabolite impurities, various analytical methods to measure impuritie, and ways to control impurities.

Pharmaceutical Technology
Troubleshooting

April 02, 2012

Critical issues that should be considered when scaling up a hot-melt extrusion process.

Pharmaceutical Technology
In the Spotlight

April 02, 2012

New product reviews for April 2012.

Pharmaceutical Technology
Guest Editorial

April 02, 2012

Collaboration can begin with a conversation.

BioForum
Pharmaceutical Technology

April 02, 2012

With financing constrained, biotechnology firms must find ways to sustain innovation.

Pharmaceutical Technology
Outsourcing Outlook

April 02, 2012

Recovery audits and other past practices in procurement can improve the bottom line.

Pharmaceutical Technology

Contract API manufacturers and fine-chemical producers roll out capacity and service expansions.

Pharmaceutical Technology
Special Features

April 02, 2012

How to use geographic diversification and legacy technology transfers to avoid product shortages.

Pharmaceutical Technology
Packaging Forum

April 02, 2012

Visitors will see many packaging innovations at the annual industry exhibition.

Pharmaceutical Technology
Agent-in Place

April 02, 2012

Failure to disclose info may work sometimes, but eventually every question will be answered.

Pharmaceutical Technology
Viewpoint

April 02, 2012

The importance of new drug trials to patients, the economy, and science.

Pharmaceutical Technology
Statistical Solutions

April 02, 2012

Understanding the differences between convenience, target, and self-selected samples.

Pharmaceutical Technology
Special Features

April 02, 2012

The authors provide an overview of the new ISPE Guide Series on Product Quality Lifecycle Implementation and how the guides can be used in a complementary way with existing guidance from FDA and the International Conference on Harmonization.

The authors discuss a new approach to address globally harmonized compendial standards.

Pharmaceutical Technology
Industry Leaders

April 02, 2012

A Q&A with Erik van den Berg, CEO of AM-Pharma, on recent industry trends.

Pharmaceutical Technology

Experts discuss the best practices for developing a QbD-based lyophilization process.

Pharmaceutical Technology

Soaring opioid use creates challenges for new drug development and supply-chain control.

Pharmaceutical Technology
Inside PIC/S

April 02, 2012

Comparison of the top GMP deficiencies cited by the PIC/S Participating Authorities.

Pharmaceutical Technology
PharmTech Talk

April 02, 2012

The confluence of science, technology, and regulation can provide path forward.

Pharmaceutical Technology
Pharma Ingredients

April 02, 2012

Excipient manufacturers expand production capacity and partner to broaden their offerings.

Pharmaceutical Technology
In the Field

April 02, 2012

China's drug-distribution network has been a mess for years, but government reforms and industry focus are unveiling new opportunities for market order and growth.

Pharmaceutical Technology
Insider Solutions

April 02, 2012

The contract provider needs to know as much as the NDA holder.

Pharmaceutical Technology
Special Features

April 02, 2012

The authors detail the possible consequences of noncompliance and a lack of quality control.

Pharmaceutical Technology

A recent survey examines the industry's views on the chief challenges and technologies in drug delivery and formulation development.

Pharmaceutical Technology

Q&A with Peter Smith and David Elder, Strategic Compliance Consulting, PAREXEL International, on acceptable deviation investigations. Smith and Elder are both former senior officials with FDA.